Study on glycemic control, weight, body fat and insulin resistance in SGLT2 inhibitor-treated Japanese patients

INTERVENTION: Take CANAGLU Tablets 100mg at the oral. 1tablet/day Period of 24 weeks Conducted blood sampling and body fat,abdominalCT ,etc. before and after intervention. CONDITION: Type 2 diabetes PRIMARY OUTCOME: HbA1c ,FPG ,Body weight ,Body mass index ,Body fat SECONDARY OUTCOME: Visceral fat area ,Waist circumference ,Amount of body fat distribution ,Lean body weight ,HOMA‐IR ,HOMA‐b ,iHOMA2 ,Blood pressure ,Lipid ,Uric acid ,eGFR ,GIR ,Liver function ,Renal function ,Adiponectin ,TNFa ,IL‐6 ,NTpro‐BNP INCLUSION CRITERIA: Informed consent obtained in writing before any trial‐related activities. Type 2 Diabetes Age <= 70 years old HbA1c between 7.0% and 10.0% BMI >= 23 kg/m2 Creatinine < 1.0mg/dL for male < 0.8mg/dL for female